Login
$PTCT
$62.09 +$1.02 (1.67%) Close

$PTCT 3 SEC Filings

Filed On Filing
30 Jul 2026 Form 3: Sollie-Zetlmayer Hege Elisabeth, Director

Holds 46,526 shares of Common Stock

26 Mar 2026 Form 3: Chutter Jessica Caroline, Director

No securities owned

17 Jul 2023 Form 3: Gravier Pierre, CHIEF FINANCIAL OFFICER

No securities owned

13 Jun 2023 Form 3: Golden Lee Scott, Chief Medical Officer

Holds 39,286 shares of Common Stock

07 Jun 2023 Form 3: Bell William F. Jr., Director

No securities owned

10 Jun 2022 Form 3: Young Alethia, Director

No securities owned

15 Jun 2021 Form 3: Smith Mary L., Director

No securities owned

17 Apr 2020 Form 3: Klein Matthew B., Chief Development Officer

Holds 0 shares of Common Stock

17 Apr 2020 Form 3: Pauwels Eric, Chief Business Officer

Holds 23,841 shares of Common Stock

03 Jun 2019 Form 3: Hill Emily Luisa, Chief Financial Officer

Holds 7,605 shares of Common Stock

18 Dec 2018 Form 3: Okey Stephanie, Director

No securities owned

18 Dec 2018 Form 3: Reeve Emma, Director

No securities owned

06 Jun 2017 Form 3: Utter Christine Marie, Principal Financial Officer

Holds 5,297 shares of Common Stock

02 Jun 2017 Form 3: Souza Marcio, Chief Operating Officer

Holds 36,457 shares of Common Stock

27 Apr 2017 Form 3: Complete Pharma Holdings II, Llc, 10% owner

Holds 6,683,598 shares of Common Stock

13 Jun 2016 Form 3: Svoronos Dawn, Director

No securities owned

27 Apr 2016 Form 3: Ong Tuyen, Chief Medical Officer
11 Jun 2015 Form 3: Steele Glenn Jr Md Phd, Director

No securities owned

11 Jun 2014 Form 3: Renaud Ronald C Jr, Director

No securities owned

03 Feb 2014 Form 3: Spiegel Robert J., Chief Medical Officer

Holds 5,455 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support